Maha M. Abdel‐Fattah
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 3
- Organic Chemistry top 10%
- Synthesis and biological activity 13
- Pharmaceutical Science top 10%
-
- Computational Drug Discovery Methods 6
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 6
- Pharmacological Effects of Natural Compounds 4
-
- Alzheimer's disease research and treatments 4
- Asthma and respiratory diseases 4
-
- Antimicrobial Peptides and Activities 3
- Co-authors
- Ahmed A. Al‐KarmalawyAyman Abo ElmaatyRasha A. HassanMuhammad KhattabWafaa R. MohamedKhaled M. DarwishAhmed S. DoghishEhab M. Gedawy
- Journals
- Molecules (1 paper)International Journal of Pharmaceutics (2 papers)Life Sciences (2 papers)
- Partner nations
- EgyptSaudi ArabiaIndia
In The Last Decade
Maha M. Abdel‐Fattah
53 papers receiving 889 citations
Peers
Comparison fields: 5 of 106
- Toxicology 45
- Organic Chemistry 271
- Pharmaceutical Science 55
- Computational Theory and Mathematics 125
- Pharmacology 66
Countries citing papers authored by Maha M. Abdel‐Fattah
This map shows the geographic impact of Maha M. Abdel‐Fattah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha M. Abdel‐Fattah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha M. Abdel‐Fattah more than expected).
Fields of papers citing papers by Maha M. Abdel‐Fattah
This network shows the impact of papers produced by Maha M. Abdel‐Fattah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha M. Abdel‐Fattah. The network helps show where Maha M. Abdel‐Fattah may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maha M. Abdel‐Fattah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 8 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 22 | |
| 15 | 2023 | 15 | |
| 16 | 2022 | 13 | |
| 17 | 2022 | 25 | |
| 18 | 2021 | 62 | |
| 19 | DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW SUCCINIMIDE, 2-IMINOTHIAZOLINE AND OXAZINE DERIVATIVES BASED BENZOPYRONE AS ANTICONVULSANT AGENTS | 2016 | 8 |
| 20 | Diversity and Environmental Stress Responses of Rhizobial Bacteria from Egyptian Grain Legumes | 2012 | 19 |
About Maha M. Abdel‐Fattah
Maha M. Abdel‐Fattah is a scholar working on Toxicology, Microbiology and Pharmacology, having authored 58 papers that have together received 902 indexed citations. Recurring topics across this work include Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (6 papers), Inflammatory mediators and NSAID effects (6 papers), Pharmacological Effects of Natural Compounds (4 papers), Alzheimer's disease research and treatments (4 papers), Asthma and respiratory diseases (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Toxicology (45 citations), Organic Chemistry (271 citations) and Pharmaceutical Science (55 citations). Maha M. Abdel‐Fattah has collaborated with scholars based in Egypt, Saudi Arabia and India. Frequent co-authors include Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, Rasha A. Hassan, Muhammad Khattab, Wafaa R. Mohamed, Khaled M. Darwish, Ahmed S. Doghish, Ehab M. Gedawy, Asmaa E. Kassab and Basim Anwar Shehata Messiha. Their work appears in journals such as Molecules, International Journal of Pharmaceutics and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.